A new phase of trials to test two promising HIV vaccines began last week in London and Oxford. The vaccines—one made of naked DNA, the other a weakened pox virus—contain genes from a common strain of HIV in Africa, and should provoke an immune response that fends off the virus itself. Volunteers are receiving different combinations of the vaccines or a placebo. Teams at Imperial College in London and the Medical Research Council’s Human Immunology Unit in Oxford hope to recruit 120 volunteers aged 18 to 60, who must be HIV-negative.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
3
The distant world that is our best hope of finding alien life
4
How I used psychology to come back from the worst year of my life
5
Photos reveal unexpected details from the world's first atomic test
6
The ‘doomsday’ glacier’s giant ice shelf is about to break away
7
Mystery of the ancient giant stone jars of Laos may have been solved
8
Epic dreaming is leaving people exhausted and distressed
9
Women’s better memories may delay Alzheimer’s diagnosis by years
10
Colossal claims an artificial eggshell will help it bring back the moa
